Study identifies new gene that can increase chemotherapeutic response in medulloblastomas


An international team led by the Department of Neurosurgery, Niigata University, has identified a new gene called Schlafen11 (SLFN11) whose expression is tightly correlated with the response to chemotherapy in medulloblastomas, a highly malignant brain tumor affecting pediatric, adolescent, and young adult populations.

Researchers identify molecular mechanism associated with juvenile Parkinson’s

Previous article

Method tames tricky binary chlorine molecule

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations